hPSCreg®
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our Privacy Policy for details. This website uses cookies, learn more

Search results

Sort by:

Filter by:

  1. AAKIPSi001-A

    France INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (AAKIPS)
    Disease:

    Aniridia

  2. AAKIPSi002-A

    France INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (AAKIPS)
    Disease:

    Aniridia

  3. AAKIPSi003-A

    France INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (AAKIPS)
    Disease:

    Aniridia

  4. AAUe001-A (CLS1)

    Denmark Aalborg University (AAU)

  5. AAUe002-A (CLS2)

    Denmark Aalborg University (AAU)

  6. AAUe003-A (CLS3)

    Denmark Aalborg University (AAU)

  7. AAUe004-A (CLS4)

    Denmark Aalborg University (AAU)

  8. ABi001-A

    Russia Moscow Institute of Physics and Technology (National Research University) (AB)
    Disease:

    Cone dystrophy with supernormal rod response

  9. ABi002-A

    Russia Moscow Institute of Physics and Technology (National Research University) (AB)
    Disease:

    Cone dystrophy with supernormal rod response

  10. ACTe001-A (Ma01)

    United States Advanced Cell Technology, Inc. - Cellular Reprogramming unit (ACT)

  11. ACTe002-A (Ma09)

    United States Advanced Cell Technology, Inc. - Cellular Reprogramming unit (ACT)

  12. ACTe003-A (ACT-14)

    United States Advanced Cell Technology, Inc. - Cellular Reprogramming unit (ACT)

  13. AHMUi001-A

    China dongmei ji (AHMU)
    Disease:

    Leber hereditary optic neuropathy

  14. AHQUi001-A (IPS35-2)

    China Affiliated Hospital of Qingdao University (AHQU)
    Disease:

    Non rare in europe: hyperlipoproteinemia type 4

  15. AHQUi001-A-1 (IPS35-2-R)

    China Affiliated Hospital of Qingdao University (AHQU)
    Disease:

    Non rare in europe: hyperlipoproteinemia type 4

  16. AIBNi015-A (SPG1-AU01C15)

    Australia Australian Institute for Bioengineering and Nanotechnology (AIBN)
    Disease:

    Hereditary spastic paraplegia 56

  17. AIBNi016-A (SPG2-S376C1)

    Australia Australian Institute for Bioengineering and Nanotechnology (AIBN)
    Disease:

    Hereditary spastic paraplegia 56

  18. AIBNi017-A (SPGh1-S075mC2)

    Australia Australian Institute for Bioengineering and Nanotechnology (AIBN)
    Disease:

    Hereditary spastic paraplegia 56

  19. AIBNi018-A (SPGh2-S964pC6)

    Australia Australian Institute for Bioengineering and Nanotechnology (AIBN)
    Disease:

    Hereditary spastic paraplegia 56

  20. UCSFi001-A-1 (AICS-0005-050)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  21. UCSFi001-A-2 (AICS-0012-105)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  22. UCSFi001-A-3 (AICS-0016-184)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  23. UCSFi001-A-4 (AICS-0075-085)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  24. UCSFi001-A-5 (AICS-0011-027)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  25. UCSFi001-A-6 (AICS-0013-210)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  26. UCSFi001-A-7 (AICS-0017-065)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  27. UCSFi001-A-8 (AICS-0010-055)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  28. UCSFi001-A-9 (AICS-0014-006)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  29. UCSFi001-A-10 (AICS-0023-020)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  30. UCSFi001-A-11 (AICS-0024-080)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  31. UCSFi001-A-12 (AICS-0036-006)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  32. UCSFi001-A-13 (AICS-0022-037)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  33. UCSFi001-A-14 (AICS-0025-001)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  34. UCSFi001-A-15 (AICS-0025-044)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  35. UCSFi001-A-16 (AICS-0031-035)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  36. UCSFi001-A-17 (AICS-0032-019)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  37. UCSFi001-A-18 (AICS-0030-022)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  38. UCSFi001-A-19 (AICS-0033-115)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  39. UCSFi001-A-20 (AICS-0040-013)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  40. UCSFi001-A-21 (AICS-0040-035)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  41. UCSFi001-A-22 (AICS-0053-016)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  42. UCSFi001-A-23 (AICS-0054-091)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  43. UCSFi001-A-24 (AICS-0057-050)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  44. UCSFi001-A-25 (AICS-0058-067)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  45. UCSFi001-A-26 (AICS-0037-172)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  46. UCSFi001-A-27 (AICS-0048-039)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  47. UCSFi001-A-28 (AICS-0061-036)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  48. UCSFi001-A-29 (AICS-0052-003)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  49. UCSFi001-A-30 (AICS-0046-051)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  50. UCSFi001-A-31 (AICS-0069-088)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  51. UCSFi001-A-32 (AICS-0060-027)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  52. UCSFi001-A-33 (AICS-0059-036)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  53. UCSFi001-A-34 (AICS-0068-009)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  54. UCSFi001-A-35 (AICS-0080-069)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  55. UCSFi001-A-36 (AICS-0036-028)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  56. UCSFi001-A-37 (AICS-0074-026)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  57. UCSFi001-A-38 (AICS-0084-018)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  58. UCSFi001-A-39 (AICS-089-061)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  59. UCSFi001-A-40 (AICS-094-024)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  60. UCSFi001-A-41 (AICS-0034-062)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  61. UCSFi001-A-42 (AICS-0086-147)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  62. UCSFi001-A-43 (AICS-0087-031)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  63. UCSFi001-A-44 (AICS-0063-096)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  64. UCSFi001-A-45 (AICS-0090-391)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  65. UCSFi001-A-46 (AICS-0095-018)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  66. UCSFi001-A-47 (AICS-0096-074)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  67. UCSFi001-A-48 (AICS-0093-025)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  68. UCSFi001-A-55 (AICS-0078-079)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  69. UCSFi001-A-56 (AICS-0088-083)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  70. UCSFi001-A-57 (AICS-0099-020)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  71. UCSFi001-A-63 (AICS-0082-001)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  72. UCSFi001-A-66 (AICS-0114-032)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  73. UCSFi001-A-67 (AICS-0114-035)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  74. UCSFi001-A-69 (AICS-0083-005)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  75. UCSFi001-A-70 (AICS-0083-124)

    United States Allen Institute for Cell Science (AICS)
    Disease:

    Normal

  76. AMUFAHi001-A

    China The First Affiliated Hospital of Anhui Medical University (AMUFAH)
    Disease:

    Normal

  77. AMUFAHi002-A (AY20210813)

    China The First Affiliated Hospital of Anhui Medical University (AMUFAH)
    Disease:

    Polycystic ovary syndrome

  78. AMUFAHi003-A

    China The First Affiliated Hospital of Anhui Medical University (AMUFAH)
    Disease:

    Normal

  79. WAe009-A-36 (JPH2-KO)

    China Anzhen Hospital (ANZHEN)
    Disease:

    Hypertrophic cardiomyopathy

  80. WAe009-A-59 (dHAND KO)

    China Anzhen Hospital (ANZHEN)
    Disease:

    Congenital heart disease

  81. WAe009-A-61

    China Anzhen Hospital (ANZHEN)
    Disease:

    Hypertrophic cardiomyopathy

  82. WAe009-A-62 (KCNQ1 KO)

    China Anzhen Hospital (ANZHEN)
    Disease:

    Long qt syndrome 1

  83. WAe009-A-69

    China Anzhen Hospital (ANZHEN)
    Disease:

    Hypertrophic cardiomyopathy

  84. WAe009-A-72 (COL1A2 -/-)

    China Anzhen Hospital (ANZHEN)
    Disease:

    Ehlers-danlos syndrome

  85. WAe009-A-79

    China Anzhen Hospital (ANZHEN)
    Disease:

    Long qt syndrome 1

  86. WAe009-A-89

    China Anzhen Hospital (ANZHEN)
    Disease:

    Sorsby fundus dystrophy

  87. ASGRCi001-A (F3-2#5 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Normal

  88. ASGRCi002-A (F3-3#1 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 1 diabetes mellitus

  89. ASGRCi003-A (F3-4#5 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 1 diabetes mellitus

  90. ASGRCi004-A (0118 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Proliferative diabetic retinopathy

    Disease:

    Type 2 diabetes mellitus

  91. ASGRCi005-A (0622 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 2 diabetes mellitus

    Disease:

    Keratoconjunctivitis sicca

  92. ASGRCi006-A (0808 CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 2 diabetes mellitus

    Disease:

    Proliferative diabetic retinopathy

  93. ASGRCi007-A (T2D19#2 XY-CHR)

    Taiwan Genomics Research Center (ASGRC)
    Disease:

    Type 2 diabetes mellitus

  94. HVRDe009-A-2 (HUES9 CTNNB1 3X FLAG)

    United States Arizona State University (ASU)
    Disease:

    Normal

  95. ATCi002-A

    China Aegicare (Shenzhen) Technology Co (ATC)
    Disease:

    Keipert syndrome

  96. ATLABi001-A (AT-MODY3-iP001)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes

  97. ATLABi002-A (AT-MODY3-iP002)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes

  98. ATLABi003-A (AT-Normal-i70)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  99. ATLABi004-A (AT-Normal-i173)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  100. ATLABi005-A (AT-Normal-i104)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  101. ATLABi006-A (AT-UC C Normal-iC16)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  102. ATLABi007-A (AT-UC C Normal-iC46)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  103. ATLABi008-A (AT-UC I Normal-iC06)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  104. ATLABi009-A (AT-UC I Normal-iC13)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  105. ATLABi010-A (AT-MODY10-iII1)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  106. ATLABi011-A (AT-MODY10-iII4)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  107. ATLABi012-A (AT-M10 Normal-iI2)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  108. ATLABi013-A (AT-M10 Normal-iII3)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  109. ATLABi014-A (AT-MODY10-iI1)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  110. ATLABi015-A (AT-Diabetic-i131)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Diabetes mellitus

  111. ATLABi016-A (AT-Diabetic-i107)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Diabetes mellitus

  112. AUi001-A

    Denmark Aarhus University (AU)
    Disease:

    Herpes simplex encephalitis

  113. AXORe001-A (Shef-1)

    United Kingdom Axordia Ltd. (AXOR)

  114. AXORe002-A (Shef-2)

    United Kingdom Axordia Ltd. (AXOR)

  115. AXORe004-A (Shef-4)

    United Kingdom Axordia Ltd. (AXOR)

  116. AXORe005-A (Shef-5)

    United Kingdom Axordia Ltd. (AXOR)

  117. AXORe007-A (Shef-7)

    United Kingdom Axordia Ltd. (AXOR)

  118. BBANTWi001-A (iPSC_FB_M45-50_C9)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Normal

  119. BBANTWi001-B (iPSC_FB_M45-50_C15)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Normal

  120. BBANTWi001-C (iPSC_FB_M45-50_C3)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Normal

  121. BBANTWi006-A (iPSC_BrS9_FB_C7)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Brugada syndrome 1

  122. BBANTWi007-A (iPSC_BrS10_FB_C3)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Brugada syndrome 1

  123. BBANTWi008-A (iPSC_PBMC_LDS_SMAD3_T1_C11)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Loeys-dietz syndrome 3

  124. BBANTWi009-A

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Meester-loeys syndrome

  125. BBANTWi010-A (iPSC_PBMC_LDS_TGFB3_KE2M_C9)

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Loeys-dietz syndrome 5

  126. BBANTWi011-A

    Belgium Biobank Antwerpen (BBANTW)
    Disease:

    Familial thoracic aortic aneurysm and aortic dissection

  127. BCHe001-A (CHB-7)

    United States Children's Hospital (BCH)

  128. BCHe002-A (CHB-8)

    United States Children's Hospital (BCH)

  129. BCHe003-A (CHB-9)

    United States Children's Hospital (BCH)

  130. BCHe004-A (CHB-10)

    United States Children's Hospital (BCH)

  131. BCHe005-A (CHB-11)

    United States Children's Hospital (BCH)

  132. BCHe006-A (CHB-12)

    United States Children's Hospital (BCH)

  133. BCHNi001-A (BCHi001-A)

    China Beijing Children′s Hospital：Department of Nephrology (BCHN)
    Disease:

    Bardet-biedl syndrome

  134. BCHNCi001-A

    China Beijing Children's Hospital, Center of Neurology (BCHNC)
    Disease:

    Early infantile epileptic encephalopathy

  135. BCMi001-A (M22c5 and HSCC-003iPS-Sc5)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal

  136. BCMi001-B (M22c8 and HSCC-003iPS-Sc8)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal

  137. BCMi002-A (LZ02)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal

  138. BCRTi001-A (P01-1)

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Fibrodysplasia ossificans progressiva

  139. BCRTi002-A (P02-1)

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Fibrodysplasia ossificans progressiva

  140. BCRTi004-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Normal

  141. BCRTi005-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Normal

  142. BCRTi006-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Focal segmental glomerulosclerosis

  143. BCRTi007-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Polycystic kidney disease

  144. BCRTi009-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Diabetic nephropathy

  145. BCRTi010-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Normal

  146. BCRTi011-A

    Germany Berlin-Brandenburg Center for Regenerative Therapies (BCRT)
    Disease:

    Neurofibromatosis type 1

  147. BGUi001-A (BGU01iPORhet)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    P450 oxidoreductase deficiency

  148. BGUi002-A (BGU02iPOR)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    P450 oxidoreductase deficiency

  149. BGUi003-A (BGU03iPOR)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    P450 oxidoreductase deficiency

  150. BGUi004-A (BGU101iCCHS)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Congenital central hypoventilation syndrome

  151. BGUi005-A (BGU102iCCHS)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Congenital central hypoventilation syndrome

  152. BGUi008-A (DCM-C)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Left ventricular noncompaction cardiomyopathy

  153. BGUi009-A (DCM-O)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Left ventricular noncompaction cardiomyopathy

  154. BGUi010-A (DCM-R)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Left ventricular noncompaction cardiomyopathy

  155. BGUi011-A (BGU01iGRIN2D)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Developmental and epileptic encephalopathy, 46

  156. BGUi012-A (BGU02iGRIN2D CTR)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Normal

  157. BGUi013-A (Omentum, BGU-hiPS and BGU-iPSCs)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Normal

  158. BGUi014-A (BGUiEMF and EMF-iPSCs)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Normal

  159. BGUi015-A (BGUiBJ)

    Israel Ben Gurion University of the Negev (BGU)
    Disease:

    Normal

  160. BIHi001-A (BCRT-3 and BCRT#1)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  161. BIHi001-A-1 (iBCRT Cas9v1-3G-Kl.16)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  162. BIHi001-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  163. BIHi002-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Autosomal recessive osteopetrosis 4

  164. BIHi004-A (NHDF Epi5 Cl5 iPSC)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  165. BIHi004-B (NHDF Epi5 Cl2 iPSC)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  166. BIHi005-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  167. BIHi005-A-4

    Germany Berlin Institute of Health (BIH)
    Disease:

    Myocardial infarction

  168. BIHi005-A-5

    Germany Berlin Institute of Health (BIH)
    Disease:

    Obsolete_alzheimer's disease

  169. BIHi006-D

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  170. BIHi007-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  171. BIHi008-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  172. BIHi009-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  173. BIHi010-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  174. BIHi011-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  175. BIHi012-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  176. BIHi015-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  177. BIHi016-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  178. BIHi017-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  179. BIHi018-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  180. BIHi019-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  181. BIHi024-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  182. BIHi025-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  183. BIHi028-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  184. BIHi029-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  185. BIHi030-C

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  186. BIHi031-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  187. BIHi032-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  188. BIHi038-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Focal segmental glomerulosclerosis

  189. WTSIi227-A-1 (WETU LRP2 KO)

    Germany Berlin Institute of Health (BIH)
    Disease:

    Donnai-barrow syndrome

  190. BIHi250-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  191. BIHi266-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  192. BIHi267-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Leigh disease

  193. BIHi269-B

    Germany Berlin Institute of Health (BIH)
    Disease:

    Normal

  194. BIHi276-A

    Germany Berlin Institute of Health (BIH)
    Disease:

    Leigh disease

  195. BIOi002-A

    China Beijing Institute of Ophthalmology (BIO)
    Disease:

    Autosomal dominant optic atrophy

  196. BIOi003-A (LYN-C1-P6)

    China Beijing Institute of Ophthalmology (BIO)
    Disease:

    Hereditary retinal dystrophy

  197. SIGi001-A-14 (SIGi001-A Bi-Allelic MAPT HA-tag)

    Denmark Bioneer (BION)
    Disease:

    Normal

  198. SIGi001-A-15 (SIGi001-A Dox inducible NGN2)

    Denmark Bioneer (BION)
    Disease:

    Normal

  199. SIGi001-A-16 (SIGi001-A-9 Bi-Allelic MAPT HA-tag)

    Denmark Bioneer (BION)
    Disease:

    Frontotemporal dementia

  200. SIGi001-A-17 (SIGi001-A-9 Dox inducible NGN2)

    Denmark Bioneer (BION)
    Disease:

    Normal

  201. SIGi001-A-18 (SIGi001-A-12 Bi-Allelic MAPT HA-tag #U28-12-P29-5)

    Denmark Bioneer (BION)
    Disease:

    Normal

  202. SIGi001-A-19 (SIGi001-A-12 Dox inducible NGN2)

    Denmark Bioneer (BION)
    Disease:

    Normal

  203. RCi004-A-1 (RCi004-A + HTT GC #H34-32_T34-23)

    Denmark Bioneer (BION)
    Disease:

    Huntington disease

  204. STBCi006-A-1 (ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  205. STBCi006-A-3 (ApoE 3/3)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  206. STBCi006-A-4 (ApoE 3/4)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  207. BIONi010-A (K1P53)

    Denmark Bioneer (BION)
    Disease:

    Normal

  208. BIONi010-B (K2P53 and BIONi010-B)

    Denmark Bioneer (BION)
    Disease:

    Normal

  209. BIONi010-C (BIONi010-C and K3P53)

    Denmark Bioneer (BION)
    Disease:

    Normal

  210. BIONi010-C-2 (BIONi010-C ApoE E3/E3 #H8 P32)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  211. BIONi010-C-3 (BIONi010-C ApoE KO #KO30 P30)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  212. BIONi010-C-4 (BIONi010-C ApoE E4/E4 #B44 P27)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  213. BIONi010-C-5 (BIONi010-C CD33 E2del #N14 P26)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  214. BIONi010-C-6 (BIONi010-C ApoE E2/E2)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  215. BIONi010-C-7 (BIONi010-C Trem2 R47H)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  216. BIONi010-C-8 (BIONi010-C Trem2 T66M and #Y5-80)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  217. BIONi010-C-9 (BIONi010-C CD33 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  218. BIONi010-C-10 (HNF1AP291fsinsC +/- 54-5)

    Denmark Bioneer (BION)
    Disease:

    Mody

  219. BIONi010-C-11 (HNF1AP291fsinsC -/- 66-1)

    Denmark Bioneer (BION)
    Disease:

    Mody

  220. BIONi010-C-12 (HNF4ApR309C -/- 2-4)

    Denmark Bioneer (BION)
    Disease:

    Mody

  221. BIONi010-C-13 (BIONi010-C + NGN2 #I7-26)

    Denmark Bioneer (BION)
    Disease:

    Normal

  222. BIONi010-C-15 (BIONi010-C +dox inducible NGN2-GFP)

    Denmark Bioneer (BION)
    Disease:

    Normal

  223. BIONi010-C-17 (BIONi010-C TREM2 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  224. BIONi010-C-18 (BIONi010-C TBK1 KO)

    Denmark Bioneer (BION)
    Disease:

    Inflammatory disease

  225. BIONi010-C-19 (BIONi010-C IKBKE KO)

    Denmark Bioneer (BION)
    Disease:

    Normal

  226. BIONi010-C-24 (BIONi010-C Dox a-syn)

    Denmark Bioneer (BION)
    Disease:

    Normal

  227. BIONi010-C-25 (BIONi010-C heterozygous TREM2 KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  228. BIONi010-C-41 (BIONi010-C + iNGN2 Two-plasmid system/CRISPR-2)

    Denmark Bioneer (BION)
    Disease:

    Normal

  229. BIONi010-C-42 (BIONi010-C + iCRE AAVS1)

    Denmark Bioneer (BION)
    Disease:

    Normal

  230. BIONi010-C-43 (BIONi010-C + aSNCA-wt AAVS1)

    Denmark Bioneer (BION)
    Disease:

    Normal

  231. BIONi010-C-44 (BIONi010-C + aSNCA-A53T AAVS1)

    Denmark Bioneer (BION)
    Disease:

    Normal

  232. BIONi010-C-45 (BIONi010-C iCRE AAVS1 GBA1 LoxP EX5-6)

    Denmark Bioneer (BION)
    Disease:

    Normal

  233. BIONi010-C-49 (BIONi010-C + synapsin-m2rtTA + SNCA-wt)

    Denmark Bioneer (BION)
    Disease:

    Normal

  234. BIONi010-C-50 (BIONi010-C + synapsin-m2rtTA + SNCA-A53T)

    Denmark Bioneer (BION)
    Disease:

    Normal

  235. BIONi010-C-51

    Denmark Bioneer (BION)
    Disease:

    Normal

  236. BIONi010-C-52 (BIONi010-C with an APOE 2/2 genotype (with two functional alleles in contrast to BIONi010-C-6))

    Denmark Bioneer (BION)
    Disease:

    Normal

  237. BIONi010-C-53 (BIONi010-C with an APOE 3/3 genotype (with two functional alleles in contrast to BIONi010-C-2))

    Denmark Bioneer (BION)
    Disease:

    Normal

  238. BIONi010-C-54 (BIONi010-C with an APOE 4/4 genotype (with two functional alleles in contrast to BIONi010-C-4))

    Denmark Bioneer (BION)
    Disease:

    Normal

  239. BIONi010-C-55 (BIONi010-C TNNI3-mCherry/TNNI1-EGFP dual reporter cl. 74)

    Denmark Bioneer (BION)
    Disease:

    Normal

  240. BIONi010-C-64 (BIONi010-C-T2A-Nanoluciferase reporter cl. 29)

    Denmark Bioneer (BION)
    Disease:

    Normal

  241. UKBi011-A-1 (iLB-AD + ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  242. UKBi011-A-2 (ApoE 2/2)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  243. UKBi011-A-3 (ApoE 3/3)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  244. UKBi011-A-4 (ApoE 3/4)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  245. BIONi013-A (H240715 47-1 and SAMEA4342502)

    Denmark Bioneer (BION)
    Disease:

    Normal

  246. BIONi014-A (H270715 47-1 and SAMEA4342566)

    Denmark Bioneer (BION)
    Disease:

    Normal

  247. BIONi015-A (H280715 47-1 and SAMEA4342649)

    Denmark Bioneer (BION)
    Disease:

    Normal

  248. BIONi016-A (H310715 47-1)

    Denmark Bioneer (BION)
    Disease:

    Normal

  249. BIONi017-A (H030815 47-1 and SAMEA4451663)

    Denmark Bioneer (BION)
    Disease:

    Normal

  250. BIONi018-A (H050815 48-4 and SAMEA4451665)

    Denmark Bioneer (BION)
    Disease:

    Normal

  251. BIONi019-A (H060815 48-3 and SAMEA4451667)

    Denmark Bioneer (BION)
    Disease:

    Normal

  252. BIONi020-A (H070815 47-2 and SAMEA4451669)

    Denmark Bioneer (BION)
    Disease:

    Normal

  253. BIONi021-A (H100815 48-2 and SAMEA4451671)

    Denmark Bioneer (BION)
    Disease:

    Normal

  254. BIONi022-A (H110815 47-2 and SAMEA4451673)

    Denmark Bioneer (BION)
    Disease:

    Normal

  255. BIONi023-A (H130815 47-4 and SAMEA4454014)

    Denmark Bioneer (BION)
    Disease:

    Normal

  256. BIONi024-A (H170815 47-2 and SAMEA4454016)

    Denmark Bioneer (BION)
    Disease:

    Normal

  257. BIONi025-A (H210815 48-3 and SAMEA4454018)

    Denmark Bioneer (BION)
    Disease:

    Normal

  258. BIONi026-A (H300715 48-3)

    Denmark Bioneer (BION)
    Disease:

    Normal

  259. BIONi027-A (H040815 48-1 and SAMEA4455499)

    Denmark Bioneer (BION)
    Disease:

    Normal

  260. BIONi028-A (H120815 48-1 and SAMEA4455501)

    Denmark Bioneer (BION)
    Disease:

    Normal

  261. BIONi029-A (H190815 47-1 and SAMEA4455503)

    Denmark Bioneer (BION)
    Disease:

    Normal

  262. BIONi030-A (H200815 47-1 and SAMEA4455505)

    Denmark Bioneer (BION)
    Disease:

    Normal

  263. BIONi031-A (H240815 48-2 and SAMEA4455507)

    Denmark Bioneer (BION)
    Disease:

    Normal

  264. BIONi032-A (H250815 48-1 and SAMEA4455509)

    Denmark Bioneer (BION)
    Disease:

    Normal

  265. BIONi033-A (H180615 and SAMEA4563389)

    Denmark Bioneer (BION)
    Disease:

    Normal

  266. BIONi034-A (H290715 and SAMEA4563391)

    Denmark Bioneer (BION)
    Disease:

    Normal

  267. BIONi035-A (H180815 and SAMEA4563393)

    Denmark Bioneer (BION)
    Disease:

    Normal

  268. BIONi037-A (16423 ApoE3/3 (control line))

    Denmark Bioneer (BION)
    Disease:

    Normal

  269. BIONi037-A-1 (16423 ApoE KO)

    Denmark Bioneer (BION)
    Disease:

    Alzheimer disease

  270. BIOTi001-A (BIOT-7183-PSEN1)

    Hungary BioTalentum Ltd. (BIOT)
    Disease:

    Obsolete_alzheimer's disease

  271. BIUi001-A (T1A1i-001)

    Israel Bar Ilan University (BIU)
    Disease:

    Obsolete: nuclear cell envelopathy

  272. BIUi002-A (T1A1i-002)

    Israel Bar Ilan University (BIU)
    Disease:

    Obsolete: nuclear cell envelopathy

  273. BJMUe001-A (PKU1)

    China Peking University Third Hospital (BJMU)

  274. BJMUe002-A (PKU2)

    China Peking University Third Hospital (BJMU)

  275. BJMUe003-A (B4)

    China Peking University Third Hospital (BJMU)

  276. BJMUe004-A (B7)

    China Peking University Third Hospital (BJMU)

  277. BJTTHi001-A

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Normal

  278. BJTTHi001-A-1

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Epilepsy

  279. BJTTHi001-A-2

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Dravet syndrome

    Disease:

    Epilepsy

  280. BJTTHi001-A-3

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Epilepsy

  281. BJTTHi001-A-4

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Epilepsy

  282. BJTTHi001-A-5

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Epilepsy

  283. BRCi021-A (TUH1)

    Japan RIKEN BioResource Research Center (BRC)
    Disease:

    Cardiomyopathy

  284. BIONi037-A-2 (BIONi037-A ApoE2/2 #M10-7)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer disease

  285. BIONi037-A-3 (BIONi037-A ApoE3/4 #P10-22)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer disease

  286. BIONi037-A-4 (BIONi037-A ApoE4/4 #I10-53)

    Denmark Bioneer (BSC)
    Disease:

    Alzheimer disease

  287. BUCREMi001-A (iPSC-S6D63H-1-hom)

    United States Boston University (BUCREM)
    Disease:

    Lethal brain and heart developmental defects

  288. BUCREMi002-A (iPSC-S6D63H-3hom)

    United States Boston University (BUCREM)
    Disease:

    Lethal brain and heart developmental defects

  289. CABi002-A (OF0176-EYS02-C7 and EYS02-MiPS4F7)

    Spain CABIMER (Andalusian Molecular Biology and Regenerative Medicine Centre) (CAB)
    Disease:

    Retinitis pigmentosa

  290. CABi003-A (DH05 and AMDdh05-MiPS4F16)

    Spain CABIMER (Andalusian Molecular Biology and Regenerative Medicine Centre) (CAB)
    Disease:

    Age-related macular degeneration

  291. CAMi001-A (KiPS c1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  292. CAMi002-A (FiPS 2a)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  293. CAMi002-B (FiPS 2b)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  294. CAMi002-C (FiPS 2c)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  295. CAMi004-A (AdiPS 1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  296. CAMi005-A (O27Tat)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  297. CAMi005-B (2F8)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  298. CAMi014-A (A1ATD1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Alpha-1-antitrypsin deficiency

  299. CAMe001-A (HNES-1 and HNES1)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  300. WISe001-A-1

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  301. CAMe002-A (HNES-3 and HNES3)

    United Kingdom University of Cambridge (CAM)
    Disease:

    Normal

  302. CBi001-A (XLC-348)

    United States Creative Bioarray (CB)
    Disease:

    Obsolete_schizophrenia

  303. CBi002-A (XLC303 and CSC-C00122)

    United States Creative Bioarray (CB)
    Disease:

    Obsolete_schizophrenia

  304. CBCHi001-A-1

    China Beijing Chest Hospital (CBCH)
    Disease:

    Hypertrophic cardiomyopathy

  305. CBDTi001-A

    India Institute for Stem Cell Science and Regenerative Medicine (CBDT)
    Disease:

    Normal

  306. CBIGi001-A (AIW002-02)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Normal

  307. CBIGi001-A-1 (PRKN-KO and PRKN-KO/AIW002-02)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson's disease

  308. CBIGi001-A-2 (PINK1-KO and PINK1-KO/AIW002-02)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson's disease

  309. CBIGi001-A-3 (PINK1-KO/PRKN-KO/AIW002-02 and PINK1-KO/PRKN-KO)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson's disease

  310. CBIGi002-A (2890 (GBA W378G, heterozygous) and 2890)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson's disease

  311. CBIGi002-A-1 (GBA W378G-correction/2890 and 2890-iso)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson's disease

  312. CBIGi003-A (3026 and 3026 (GBA N370S, heterozygous))

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson's disease

  313. CBIGi003-A-1 (3026-iso and GBA N370S-correction/3026)

    Canada Clinical Biospecimen Imaging and Genetic (C-BIG) Repository (CBIG)
    Disease:

    Parkinson's disease

  314. CBRCULi001-A (13-6545-1)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Normal

  315. CBRCULi002-A (19-1035-10)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Myotonic dystrophy type 1

  316. CBRCULi003-A (59-0944-2)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Myotonic dystrophy type 1

  317. CBRCULi004-A (79-1660-2)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Myotonic dystrophy type 1

  318. CBRCULi005-A (91-3158-1)

    Canada CERVO Brain Research Centre-Université Laval (CBRCUL)
    Disease:

    Myotonic dystrophy type 1

  319. CCMi007-A (SAS1 C5)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Covid-19 infection

  320. CCMi008-A (SAS2 C1)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Covid-19 infection

  321. CCMi009-A (SAS3 C10)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Covid-19 infection

  322. CCMi011-A (SAS7 C6)

    Italy Centro Cardiologico Monzino IRCCS (CCM)
    Disease:

    Covid-19 infection

  323. TMOi001-A-1 (hiPSC-CD34-GFP-3G6)

    Austria St. Anna Kinderkrebsforschung GmbH (CCRI)
    Disease:

    Normal

  324. CDIi001-A (01279)

    United States FUJIFILM Cellular Dynamics, Inc. (CDI)
    Disease:

    Normal

  325. CDIi002-A (01434)

    United States FUJIFILM Cellular Dynamics, Inc. (CDI)
    Disease:

    Normal

  326. CDIi004-A (11713)

    United States FUJIFILM Cellular Dynamics, Inc. (CDI)
    Disease:

    Normal

  327. CEBi001-A (Cellartis Human iPS Cell Line 22)

    France Takara Bio Europe AB (former Cellartis) (CEB)
    Disease:

    Normal

  328. CEBe001-A (FC018)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)
    Disease:

    Klinefelter syndrome

  329. CEBe002-A (AS034)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  330. CEBe002-A-1 (AS034.1)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  331. CEBe002-A-2 (AS034.2)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  332. CEBe002-A-3 (AS034.1.1)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  333. CEBe006-A (AS038)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  334. CEBe007-A (SA046)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  335. CEBe008-A (AS079)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  336. CEBe009-A (SA085)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  337. CEBe010-A (SA094)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  338. CEBe011-A (SA111)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  339. CEBe012-A (SA121)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  340. CEBe013-A (SA142)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  341. CEBe014-A (SA167)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  342. CEBe015-A (SA181)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  343. CEBe016-A (SA191)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  344. CEBe017-A (SA196)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  345. CEBe018-A (SA202)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  346. CEBe019-A (SA203)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  347. CEBe020-A (SA211)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  348. CEBe021-A (SA218)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  349. CEBe022-A (SA240)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  350. CEBe023-A (SA348)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  351. CEBe024-A (SA279)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  352. CEBe025-A (SA352)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  353. CEBe026-A (SA399)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  354. CEBe027-A (SA461)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  355. CEBe028-A (SA502)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  356. CEBe029-A (SA506)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  357. CEBe030-A (SA521)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  358. CEBe031-A (SA540)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  359. CEBe032-A (SA611)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  360. CEBe033-A (SA001)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)
    Disease:

    Normal

  361. CEBe034-A (SA002)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)
    Disease:

    Patau syndrome

  362. CEBe034-A-1 (SA002.5)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)
    Disease:

    Patau syndrome

  363. CEBe035-A (SA003)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)

  364. CEGHUi001-A (iPSC_CEGH_C2)

    Brazil Human Genome and Stem Cell Research Center, University of São Paulo (CEGHU)
    Disease:

    Normal

  365. CENSOi001-B (FB78R2c2 and CENSOi249)

    United Kingdom Censo an Axol Bioscience Company (CENSO)
    Disease:

    Duchenne muscular dystrophy

  366. CENSOi002-B (FB74R2c4 and CENSOi261)

    United Kingdom Censo an Axol Bioscience Company (CENSO)
    Disease:

    Duchenne muscular dystrophy

  367. CENSOi003-B (FB79R2c6 and CENSOi258)

    United Kingdom Censo an Axol Bioscience Company (CENSO)
    Disease:

    Duchenne muscular dystrophy

  368. CENSOi005-A (FB76R2c5 and CENSOi245)

    United Kingdom Censo an Axol Bioscience Company (CENSO)
    Disease:

    Duchenne muscular dystrophy

  369. CENSOi007-A (FB75R2c5 and CENSOi255)

    United Kingdom Censo an Axol Bioscience Company (CENSO)
    Disease:

    Duchenne muscular dystrophy

  370. CENSOi008-A (FB77R2c3 and CENSOi260)

    United Kingdom Censo an Axol Bioscience Company (CENSO)
    Disease:

    Myotonic dystrophy type 1

  371. CHAe001-A (CHA-hES3)

    South Korea Pochon CHA University (CHA)

  372. CHAe002-A (CHA-hES4)

    South Korea Pochon CHA University (CHA)

  373. CHAHESe001-A (CHA-hES NT6 and CHA-NTK6)

    South Korea CHA University (CHAHES)
    Disease:

    Age-related macular degeneration

  374. CHCMUi001-A

    China Children's hospital of Chongqing Medical University (CHCMU)
    Disease:

    Activated pi3k-delta syndrome

  375. CHDIi001-A (#1c8 and CHDI-90002149)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  376. CHDIi002-A (#2c3 and CHDI-90002150)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  377. CHDIi003-A (#3c1 and CHDI-90002151)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  378. CHDIi004-A (#4c2 and CHDI-90002152)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  379. CHDIi005-A (#5c4 and CHDI-90002153)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  380. CHDIi006-A (#6c7 and CHDI-90002154)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  381. CHDIi008-A (#8c3 and CHDI-90002156)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  382. CHDIi010-A (#10c2 and CHDI-90002158)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  383. CHDIi011-A (#11c2 and CHDI-90002159)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  384. CHDIi013-A (#13c5 and CHDI-90002161)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  385. CHDIi014-A (#14c1 and CHDI-90002162)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  386. CHDIi016-A (#16c6 and CHDI-90002164)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  387. CHDIi017-A (#17c1 and CHDI-90002165)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  388. CHDIi018-A (#18c1 and CHDI-90002166)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  389. CHDIi019-A (#19c9 and CHDI-90002167)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  390. CHDIi020-A (#20c2 and CHDI-90002168)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  391. CHDIi021-A (#21c5 and CHDI-90002169)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  392. CHDIi022-A (#22c1 and CHDI-90002170)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  393. CHDIi023-A (#23c8 and CHDI-90002171)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  394. CHDIi024-A (#24c7 and CHDI-90002172)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  395. CHDIi026-A (#26c3 and CHDI-90002174)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  396. CHDIi027-A (#27c4 and CHDI-90002175)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  397. CHDIi028-A (#28c3 and CHDI-90002176)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  398. CHDIi029-A (#29c4 and CHDI-90002177)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  399. CHDIi031-A (#31c1 and CHDI-90002179)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  400. CHDIi033-A (#104c2 and CHDI-90002181)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  401. CHDIi034-A (#105c1 and CHDI-90002182)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  402. CHDIi035-A (#108c5 and CHDI-90002183)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  403. CHDIi036-A (#110c5 and CHDI-90002184)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  404. CHDIi038-A (#112c7 and CHDI-90002186)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  405. CHDIi040-A (#115c6 and CHDI-90002188)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  406. CHDIi041-A (#116c2 and CHDI-90002189)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  407. CHDIi042-A (#117c5 and CHDI-90002190)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  408. CHDIi043-A (#118c6 and CHDI-90002191)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  409. CHDIi044-A (#120c3 and CHDI-90002192)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  410. CHDIi045-A (#121c6 and CHDI-90002193)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  411. CHDIi046-A (#122c1 and CHDI-90002194)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  412. CHDIi047-A (#123c6 and CHDI-90002195)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  413. CHDIi048-A (#125c2 and CHDI-90002196)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  414. CHDIi049-A (#127c2 and CHDI-90002197)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  415. CHDIi050-A (#128c3 and CHDI-90002198)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  416. CHDIi051-A (#129c1 and CHDI-90002199)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  417. CHDIi054-A (#132c3 and CHDI-90002202)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  418. CHDIi055-A (#133c5 and CHDI-90002203)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  419. CHDIi056-A (#134c3 and CHDI-90002204)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  420. CHOPi001-A (CHOPJMML1854)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Juvenile myelomonocytic leukemia

  421. CHOPi005-A (LD0638.0A)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Hypomyelination with atrophy of basal ganglia and cerebellum

  422. CHOPi006-A (LD0313.0)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Hypomyelination with atrophy of basal ganglia and cerebellum

  423. CHOPi007-A

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Hypomyelination with atrophy of basal ganglia and cerebellum

  424. CHOPi008-A (TMD145.T21.G1S)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Transient abnormal myelopoiesis associated with down syndrome

  425. CHOPi008-B (TMD145.E46.G1S)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Transient abnormal myelopoiesis associated with down syndrome

  426. CHOPi008-C (DS145.T21.G1)

    United States The Children's Hospital of Philadelphia (CHOP)
    Disease:

    Transient abnormal myelopoiesis associated with down syndrome

  427. CHULAi001-A (GPDi001-A)

    Thailand Chulalongkorn University (CHULA)
    Disease:

    Glucose-6-phosphate dehydrogenase deficiency

  428. CHULAe001-A (Chula2.hES)

    Thailand Chulalongkorn University (CHULA)

  429. CHUQi001-A (522-2666-2 and SAMEA104271492)

    Canada CHU de Québec-Université Laval Research Center (CHUQ)
    Disease:

    Myotonic dystrophy type 1

  430. CHUVi001-A

    Switzerland Centre Hospitalier Universitaire Vaudois (CHUV)
    Disease:

    Normal

  431. CHWi001-A

    China The centre of prenatal diagnosis, The Central Hospital of Wenzhou (CHW)
    Disease:

    Intellectual disability

  432. CIAUi003-A (MCCIi005-A-1 and BFC4)

    Australia Centenary Institute of Cancer Medicine and Cell Biology (CIAU)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia 2

  433. CIAUi003-A-1 (BFC4-C and BFC4-CRISPR-corrected)

    Australia Centenary Institute of Cancer Medicine and Cell Biology (CIAU)
    Disease:

    Catecholaminergic polymorphic ventricular tachycardia 2

  434. CIMHi001-A (CIMHi44f028#4)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal

  435. CIMHi002-A (CIMHi29m067#3)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal

  436. CIMHi003-A (CIMHi23m035#2)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal

  437. CIMHi004-A (CIMHi24f007#4)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal

  438. CIMHi005-A (CIMHi25f100#5)

    Germany Central Institute of Mental Health (CIMH)
    Disease:

    Normal

  439. CIMRi001-A (GM27291)

    United States Coriell Institute for Medical Research (CIMR)
    Disease:

    Vici syndrome

  440. CIPi001-A

    China Children’s Hospital of Capital Institute of Pediatrics (CIP)
    Disease:

    Benign familial infantile epilepsy

  441. CIPi002-A

    China Children’s Hospital of Capital Institute of Pediatrics (CIP)

  442. CIRAi005-A (F2KU1#4 and F2KU1)

    Japan Center for iPS Cell Research and Application (CIRA)
    Disease:

    Facioscapulohumeral muscular dystrophy 2

  443. CIRAi005-A-1 (IsC2-F2KU1#4 and IsC-F2KU1)

    Japan Center for iPS Cell Research and Application (CIRA)
    Disease:

    Facioscapulohumeral muscular dystrophy 2

  444. CIRAi006-A (F2KU2#17 and F2KU2)

    Japan Center for iPS Cell Research and Application (CIRA)
    Disease:

    Facioscapulohumeral muscular dystrophy 2

  445. CIRAi006-A-1 (IsC-F2KU2 and IsC41-F2KU2#17)

    Japan Center for iPS Cell Research and Application (CIRA)
    Disease:

    Facioscapulohumeral muscular dystrophy 2

  446. CIRMi001-A (CW13000)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  447. CIRMi002-A (CW13002)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  448. CIRMi003-A (CW13003)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  449. CIRMi004-A (CW13005)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  450. CIRMi005-A (CW13006)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  451. CIRMi006-A (CW13009)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  452. CIRMi007-A (CW13011)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  453. CIRMi008-A (CW13016)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  454. CIRMi009-A (CW13017)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  455. CIRMi010-A (CW13018)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  456. CIRMi011-A (CW13020)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  457. CIRMi012-A (CW13021)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  458. CIRMi013-A (CW13023)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  459. CIRMi014-A (CW13024)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  460. CIRMi015-A (CW13025)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  461. CIRMi016-A (CW13026)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  462. CIRMi017-A (CW13028)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  463. CIRMi018-A (CW13029)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  464. CIRMi019-A (CW13030)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  465. CIRMi020-A (CW13031)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  466. CIRMi021-A (CW13032)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  467. CIRMi022-A (CW13033)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  468. CIRMi023-A (CW13034)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  469. CIRMi024-A (CW13037)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  470. CIRMi025-A (CW13038)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  471. CIRMi026-A (CW13041)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  472. CIRMi027-A (CW13042)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  473. CIRMi028-A (CW13044)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  474. CIRMi029-A (CW13045)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  475. CIRMi030-A (CW13047)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  476. CIRMi031-A (CW13048)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  477. CIRMi032-A (CW13049)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  478. CIRMi033-A (CW13052)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  479. CIRMi034-A (CW13053)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  480. CIRMi035-A (CW13055)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  481. CIRMi036-A (CW13060)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  482. CIRMi037-A (CW13061)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  483. CIRMi038-A (CW13063)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  484. CIRMi039-A (CW13064)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  485. CIRMi040-A (CW13065)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  486. CIRMi041-A (CW13066)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  487. CIRMi042-A (CW13067)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  488. CIRMi043-A (CW13070)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  489. CIRMi044-A (CW13072)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  490. CIRMi045-A (CW13073)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  491. CIRMi046-A (CW13074)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  492. CIRMi047-A (CW13075)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  493. CIRMi048-A (CW13076)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  494. CIRMi049-A (CW13077)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  495. CIRMi050-A (CW13079)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  496. CIRMi051-A (CW13088)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  497. CIRMi052-A (CW13092)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  498. CIRMi053-A (CW13093)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  499. CIRMi054-A (CW13094)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  500. CIRMi055-A (CW13095)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  501. CIRMi056-A (CW13097)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  502. CIRMi057-A (CW13098)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  503. CIRMi058-A (CW13105)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  504. CIRMi059-A (CW13107)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  505. CIRMi060-A (CW13108)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  506. CIRMi061-A (CW13109)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  507. CIRMi062-A (CW13111)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  508. CIRMi063-A (CW13112)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  509. CIRMi064-A (CW13113)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  510. CIRMi065-A (CW13054)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Normal

  511. CIRMi066-A (CW13069)

    United States California Institute for Regenerative Medicine (CIRM)
    Disease:

    Late-onset alzheimers disease

  512. CMCi001-A (CMC-KIN-hiPSC)

    South Korea Catholic University of Korea (CMC)
    Disease:

    Karyomegalic interstitial nephritis

  513. CMCi002-A (CMC-GIT-001)

    South Korea Catholic University of Korea (CMC)
    Disease:

    Gitelman syndrome

  514. CMCi006-A (CMC-Fb-001)

    South Korea Catholic University of Korea (CMC)
    Disease:

    Fabry disease

  515. CMCi006-A-1 (CMC-Fb001(A4GALT-KO))

    South Korea Catholic University of Korea (CMC)
    Disease:

    Fabry disease

  516. CMCi007-A (CMC-Fb-004)

    South Korea Catholic University of Korea (CMC)
    Disease:

    Fabry disease

  517. CMCi009-A (CMC-BHD-001)

    South Korea Catholic University of Korea (CMC)
    Disease:

    Birt-hogg-dube syndrome

  518. CMCi010-A (CMC-Fb-002)

    South Korea Catholic University of Korea (CMC)
    Disease:

    Fabry disease

  519. CMCi011-A (CMC-DENT-001)

    South Korea Catholic University of Korea (CMC)
    Disease:

    Dent disease

  520. CMFTe001-A (Man-2)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)

  521. CMFTe002-A (Man-12)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)
    Disease:

    Normal

  522. CMFTe003-A (Man-14)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)
    Disease:

    Normal

  523. CMFTe004-A (Man-16)

    United Kingdom Central Manchester and Manchester Children's University Hospitals NHS (CMFT)
    Disease:

    Normal

  524. CMGANTi003-A (SEMD1)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    X-linked spondyloepimetaphyseal dysplasia

  525. CMGANTi004-A (SEMD2)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    X-linked spondyloepimetaphyseal dysplasia

  526. CMGANTi005-A (iPSC_MFS_FBN1_MCE-KB_C8)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Marfan syndrome

  527. CMGANTi006-A (SEDC1)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Spondyloepiphyseal dysplasia congenita

  528. CMGANTi007-A (SEDC2)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Spondyloepiphyseal dysplasia congenita

  529. CMGANTi008-A (iPSC_MFS_FBN1_Fi930129_C8)

    Belgium Center of Medical Genetics Antwerp (CMGANT)
    Disease:

    Marfan syndrome

  530. CMUi002-A

    China Capital Medical University (CMU)
    Disease:

    Normal

  531. CMUi002-A-1 (NONO-KO-iPSCs)

    China Capital Medical University (CMU)
    Disease:

    Left ventricular noncompaction cardiomyopathy

    Disease:

    Mental retardation

  532. WAe009-A-73

    China Capital Medical University (CMU)
    Disease:

    Heart disease

  533. CPGHi004-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Normal

  534. CPGHi006-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Autosomal dominant polycystic kidney disease

  535. CPGHi007-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Normal

  536. CPGHi008-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Autosomal recessive polycystic kidney disease

  537. CRICKi001-A (iFCI001)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Intellectual disability

  538. CRICKi002-A (iFCI027)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Intellectual disability

  539. CRICKi004-A (iFCI008)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy with lower extremity predominant

  540. CRICKi005-A (iFCI004)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy

  541. CRICKi006-A (iFCI005)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy

  542. CRICKi007-A (iFCI009)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Spinal muscular atrophy with lower extremity predominant

  543. CRICKi008-A (iFCI006 and NH13-0078)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    X-linked centronuclear myopathy

  544. CRICKi009-A (iFCI012)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Vhl

  545. CRICKi010-A (iFCI013)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Vhl

  546. CRICKi011-A (iFCI016)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Young-onset parkinson disease

  547. CRICKi012-A (iFCI017)

    United Kingdom The Francis Crick Institute Limited (CRICK)
    Disease:

    Young-onset parkinson disease

  548. CRMi001-A (NCRM-5 and NL-5)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal

  549. CRMi003-A (NCRM-1 and NL-1)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal

  550. CRMi004-A (CR0000007, NCRM-2 and ND50030)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal

  551. CRMi005-A (CR0000011, ND50021 and ND1.4)

    United States National Institutes of Health - Center for Regenerative Medicine (CRM)
    Disease:

    Normal

  552. CRTDi001-A (T12.9 and C1-1)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  553. CRTDi003-A (CRTD2)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  554. CRTDi003-B (CRTD3)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  555. CRTDi004-A (CRTD1)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  556. CRTDi005-A (CRTD4)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  557. CRTDi005-B (CRTD5)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  558. CRTDi006-A

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 1

  559. CRTDi006-B

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 1

  560. CRTDi007-A

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 1

  561. CRTDi007-B

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 1

  562. CRTDi008-B

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 5

  563. CRTDi009-A

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 5

  564. CRTDi010-B

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Aicardi-goutieres syndrome 5

  565. CRTDi011-A (IDP52555 #9)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  566. CRTDi011-B (IDP52555 #13)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  567. CRTDi011-C (IDP52555 #36)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  568. CRTDi011-D (IDP52555 #44)

    Germany Center for Regenerative Therapies Dresden (CRTD)
    Disease:

    Normal

  569. CSMCi001-A (CS011iMEN1-n4)

    United States Cedars Sinai Medical Center, (CSMC)
    Disease:

    Multiple endocrine neoplasia type 1

  570. CSMCi001-A-1 (CS011iMEN1-n4.Homo5)

    United States Cedars Sinai Medical Center, (CSMC)
    Disease:

    Multiple endocrine neoplasia type 1

  571. CSMCi001-A-2

    United States Cedars Sinai Medical Center, (CSMC)
    Disease:

    Multiple endocrine neoplasia type 1

  572. CSSi001-A (Joub03cl2 and COR419)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Joubert syndrome

  573. CSSi002-A (HD8yrs)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Juvenile huntington disease

  574. CSSi003-A (COL04 clE2)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Smith-magenis syndrome

  575. CSSi004-A (HD256.05 cl1)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Huntington disease

  576. CSSi005-A (COL03 cl.C3)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal

  577. CSSi006-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Huntington disease

  578. CSSi007-A (Joub07 cl1 and COR11-NG708)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Joubert syndrome

  579. CSSi008-A (AT214-01-02)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Dentatorubral pallidoluysian atrophy

  580. CSSi009-A (GDB1307_Z2#1)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Gnb5-related intellectual disability-cardiac arrhythmia syndrome

  581. CSSi011-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Amyotrophic lateral sclerosis

  582. CSSi012-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Amyotrophic lateral sclerosis

  583. CSSi013-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal

  584. CSSi014-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Mucopolysaccharidosis ii

  585. CSSi015-A (FC17)

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Normal

  586. CSSi016-A

    Italy Fondazione Casa Sollievo della Sofferenza IRCCS (CSS)
    Disease:

    Charcot-marie-tooth disease type 4b3

  587. CSUe001-A (chESC-3 (H3))

    China Central South University (CSU)

  588. CSUe004-A (chHES-20)

    China Central South University (CSU)

  589. CSUe005-A (chHES-22)

    China Central South University (CSU)

  590. WAe009-A-10 (EBNA1+H9 and H9-EBNA)

    China Central South University (CSU)
    Disease:

    Normal

  591. CSUXHi001-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Spinocerebellar ataxia type 3

  592. CSUXHi002-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Spinocerebellar ataxia type 1

  593. CSUXHi003-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Waardenburg syndrome type 2

  594. CSUXHi004-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Waardenburg syndrome type 1

  595. CSUXHi005-A

    China Xiangya Hospital (CSUXH)
    Disease:

    Spinocerebellar ataxia type 3

  596. CSUXHEi001-A

    China Central South University (CSUXHE)
    Disease:

    Normal

  597. CSUXHEi002-A

    China Central South University (CSUXHE)
    Disease:

    Normal

  598. CTEFe001-A (MUCG01)

    Czech Republic Cell and Tissue Engineering Facility (CTEF)
    Disease:

    Normal

  599. CTEFe002-A (MUCG02)

    Czech Republic Cell and Tissue Engineering Facility (CTEF)
    Disease:

    Normal

  600. CTEFe003-A (MUCG03)

    Czech Republic Cell and Tissue Engineering Facility (CTEF)
    Disease:

    Normal

  601. CTGUi001-A (FD01 and F01)

    China China Three Gorges University (CTGU)
    Disease:

    Fabry disease

  602. WAe001-A-95 (CTU-hES-1)

    China GIBH (CTU)
    Disease:

    Microcephaly-capillary malformation syndrome

  603. CUBi001-A

    Germany Charité - Universitätsmedizin Berlin (CUB)
    Disease:

    Mirage syndrome

  604. CUBi002-B

    Germany Charité - Universitätsmedizin Berlin (CUB)
    Disease:

    Mirage syndrome

  605. CUIMCi004-A (1514_1)

    United States Columbia University Irving Medical Center (CUIMC)
    Disease:

    Class 3 obesity

  606. CUIMCi005-A (BB#2 and BB9068#2)

    United States Columbia University Irving Medical Center (CUIMC)
    Disease:

    Stargardt disease

  607. CVTTHi001-A

    Spain Centro Vasco de Transfusión y Tejidos Humanos (CVTTH)
    Disease:

    Activated pi3k-delta syndrome

  608. DALCe001-A (ReliCellhES1)

    India Dhirubhai Ambani Life Sciences Center (DALC)

  609. DANi001-C (iPS-CCD-C3)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Normal

  610. DANi002-C (GBA-002-C3)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  611. DANi003-H (GBA-003-C8)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  612. DANi004-A (PRKN-004-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  613. DANi005-A (LRRK2-GBA-005-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  614. DANi006-F (GBA-006-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  615. DANi007-A (PINK1-007-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  616. DANi008-F (SNCA-008-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  617. DANi009-C (SNCA-009-C3)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  618. DANi010-A (GBA-010-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  619. DANi011-A (LRRK2-011-C1)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  620. DHMi001-A (Control_S)

    Germany German Heart Center Munich (DHM)
    Disease:

    Normal

  621. DHMi002-A (HLHS_606)

    Germany German Heart Center Munich (DHM)
    Disease:

    Hypoplastic left heart syndrome

  622. DHMi003-A (HLHS_612)

    Germany German Heart Center Munich (DHM)
    Disease:

    Hypoplastic left heart syndrome

  623. DHMi004-A (HOS_1460)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  624. DHMi004-A-1 (HOS_1460corr 127 Clone 31)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  625. DHMi004-A-2 (HOS_1460_FLAG Clone 4)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  626. DHMi004-A-3 (HOS_1460corr 127 Clone 31_FLAG Clone 18)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  627. DHMi005-A (Control_L)

    Germany German Heart Center Munich (DHM)
    Disease:

    Normal

  628. DHMi005-A-1 (L_mut)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  629. DHMi005-A-2 (L_FLAG Clone 5)

    Germany German Heart Center Munich (DHM)
    Disease:

    Normal

  630. DHMi005-A-3 (L_FLAG Clone 6)

    Germany German Heart Center Munich (DHM)
    Disease:

    Normal

  631. DHMi005-A-4 (L_FLAG Clone 7)

    Germany German Heart Center Munich (DHM)
    Disease:

    Normal

  632. DHMi005-A-5 (L_mut_FLAG Clone 4)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  633. DHMi005-A-6 (L_mut_FLAG Clone 14)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  634. DHMi005-A-7 (L_mut_FLAG Clone 15)

    Germany German Heart Center Munich (DHM)
    Disease:

    Holt-oram syndrome

  635. DMBi001-A

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Normal

  636. DMBi001-A-1

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Laminin alpha 2-related dystrophy

  637. DMBi001-A-2

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Normal

  638. DMBi003-A

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Rheumatoid arthritis

  639. DMBi004-A

    Poland Department of Medical Biotechnology (DMB)
    Disease:

    Rheumatoid arthritis

  640. DPEDi001-A (T12)

    Germany Division of Paediatric Endocrinology and Diabetes (DPED)
    Disease:

    Normal

  641. DPNJMUi001-A

    China Children's Hospital of Nanjing Medical University (DPNJMU)
    Disease:

    Combined oxidative phosphorylation deficiency 23

  642. DRICUi003-A (LC56A10005A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  643. DRICUi004-A (LC56A10012A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  644. DRICUi005-A (LW44A10001A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  645. DRICUi006-A (ADANG10496CA)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  646. DRICUi007-A (ADANG10605CA)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  647. DRICUi009-A (ADLON44426UC)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Normal

  648. DRICUi010-A (BS38A10004A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  649. DRICUi011-A (BS38A10002A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  650. DRICUi012-A (NT18A10014A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  651. DRICUi013-A (SC45A10021A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Late-onset alzheimers disease

  652. DRICUi014-A (CF00C90323A)

    United Kingdom UK Dementia Research Institute, Cardiff University (DRICU)
    Disease:

    Normal

  653. WAe009-A-58 (COL4A5 heterozygote)

    China Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (DZMH)
    Disease:

    Alport syndrome

  654. EDi001-A (AST22, AST23 and SAMEA3319992)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson disease

  655. EDi001-A-1 (AST22-C and AST23-C)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson disease

  656. EDi001-A-2 (AST23-1KO-3, AST22-1KO-3, AST-23_SCAKO Clone 3 and AST-22_SNCAKO Clone 3)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson disease

  657. EDi001-A-3 (AST23_SNCAKO Clone 1, AST22-1KO-1, AST23-1KO-1 and AST22_SNCAKO Clone 1)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson disease

  658. EDi001-A-4 (AST22-2KO-6, AST23_SNCAKO Clone 6, AST22_SNCAKO Clone 6 and AST23-2KO-6)

    United States University of Edinburgh (ED)
    Disease:

    Parkinson disease

  659. EDi001-A-5 (AST23-2KO-II8B)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson disease

  660. EDi001-B (AST18)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson disease

  661. EDi001-B-1 (AST18-7A)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson disease

  662. EDi001-B-2 (AST18-7B)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson disease

  663. EDi001-B-3 (AST18-5D)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson disease

  664. EDi001-B-4 (AST18-6A)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson disease

  665. EDi002-A (NAS2)

    United States University of Edinburgh (ED)
    Disease:

    Normal

  666. EDi008-B (G51D-4, EDINi008-B, EDIi008-B and SAMEA3174606)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Parkinson disease

  667. EDi010-A (RCi136)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  668. EDi010-B (RCi138)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  669. EDi011-A (RCi139)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  670. EDi011-B (RCi140)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  671. EDi011-C (RCi141)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  672. EDi012-A (RCi163)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  673. EDi012-B (RCi164)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  674. EDi012-C (RCi165)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  675. EDi013-A (RCi192)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  676. EDi013-B (RCi193)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  677. EDi013-C (RCi214)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  678. EDi014-A (RCi175)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

    Disease:

    Anti-social behavior

  679. EDi014-B (RCi185)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

    Disease:

    Anti-social behavior

  680. EDi015-A (RCi176)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  681. EDi015-B (RCi183)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  682. EDi015-C (RCi184)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Unipolar depression

  683. EDi016-A (RCi189)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  684. EDi016-C (RCi191)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  685. EDi017-A (RCi174)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  686. EDi017-B (RCi181)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  687. EDi017-C (RCi182)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal

  688. EDi018-A (RCi211)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  689. EDi018-B (RCi212)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  690. EDi018-C (RCi213)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Bipolar disorder

  691. EDi019-A (RCi166)

    United Kingdom University of Edinburgh (ED)
    Disease:

    Normal